Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Events

Resource Hubs

DAPT: 60 Second Insights

Published: 08 October 2018

Views:
502
Likes:
7

Views:
502
Likes:
7
Share:

Now Playing
Part 1 | Session 8 of 10
Do you have a preferred approach to DAPT dosage and duration for ACS patients undergoing PCI?
Dominick J Angiolillo

Up Next
1m 1s

Part 1 | Session 9 Do you have a preferred approach to DAPT dosage and duration for stable patients undergoing PCI?
Dominick J Angiolillo
53s

Part 1 | Session 10 What are the major risk factors that should be considered before initiating DAPT in stable patients?
Dominick J Angiolillo

1m 13s

Part 1 | Session 1 Do you have a preferred strategy for patients with AF on OACs Post-PCI? Dominick J Angiolillo

1m 37s

Part 1 | Session 2 What factors do you consider when assessing when to switch? Dominick J Angiolillo

1m 4s

Part 1 | Session 3 Which scenarios would you use I.V. antiplatelet such as cangrelor? Dominick J Angiolillo

45s

Part 1 | Session 4 Which scenarios do you typically use Prasugrel +ASA? Dominick J Angiolillo

23s

Part 1 | Session 5 Which scenarios do you typically use Clopidogrel +ASA? Dominick J Angiolillo

1m 10s

Part 1 | Session 6 Which scenarios do you typically use Ticagrelor +ASA? Dominick J Angiolillo

45s

Part 1 | Session 7 Do you have a preferred stent and does this alter the DAPT approach? Dominick J Angiolillo

Average (ratings)

No ratings

Your rating

Overview

Dominick Angiollilo discusses the DAPT Trial in a series of 60-second interviews

More from this programme

Part 1

DAPT

10 sessions
Do you have a preferred strategy for patients with AF on OACs Post-PCI?	Watch now
What factors do you consider when assessing when to switch?	Watch now
Which scenarios would you use I.V. antiplatelet such as cangrelor?	Watch now
Which scenarios do you typically use Prasugrel +ASA?	Watch now
Which scenarios do you typically use Clopidogrel +ASA?	Watch now
Which scenarios do you typically use Ticagrelor +ASA?	Watch now
Do you have a preferred stent and does this alter the DAPT approach?	Watch now
Do you have a preferred approach to DAPT dosage and duration for ACS patients undergoing PCI?	Watch now
Do you have a preferred approach to DAPT dosage and duration for stable patients undergoing PCI?	Watch now
What are the major risk factors that should be considered before initiating DAPT in stable patients?	Watch now

Faculty Biographies

Dominick J Angiolillo

Dominick J Angiolillo

Professor & Chief

Dr Dominick Angiolillo graduated from the Catholic University of the Sacred Heart Medical School in Rome, Italy and pursued training in interventional cardiology at the Complutense University of Madrid in Spain and received his Ph.D. in cellular and molecular cardiology. Dr Angiolillo is board-certified in internal medicine, cardiovascular disease and interventional cardiology.

In 2004, Dr Angiolillo joined the University of Florida College of Medicine in Jacksonville, where he is a professor of medicine, director of cardiovascular research and director of the interventional cardiology fellowship program.

Dr Angiolillo has made major scientific contributions to many medical and cardiovascular journals, as well as cardiovascular medicine textbooks. He has authored more than 400 peer-reviewed articles, with nearly 30,000 citations and an H-index of 86. He has authored more than 30 book chapters and is the editor of his…

View full profile